Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
Vanessa Deveaux, Thomas Cadoudal, Yasukatsu Ichigotani et al. · 2009
Read Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis by Vanessa Deveaux, Thomas Cadoudal, Yasukatsu Ichigotani et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005844.txt.
Description
Vanessa Deveaux and co-authors reported in 2009 that a cannabis-related receptor worsens obesity-linked inflammation and liver fat. In obesity, inflamed fat tissue drives insulin resistance and fatty liver disease. The CB2 receptor, found on immune cells, regulates innate immunity.
Activating CB2, the team found, made those problems worse, not better, in their models. That result surprised some expectations for cannabinoid drugs in metabolic care and weight control. It warns that CB2-targeted medicines could harm metabolic health. Knowing the receptor's true role in obesity helps set safe directions for drug development around the endocannabinoid system.
Catalog record
| CREATOR | Vanessa Deveaux, Thomas Cadoudal, Yasukatsu Ichigotani et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005844